Adult Retinal Stem Cells

Schepens Eye Research Institute
posted on 03/04/2009

A non-embryonic self-propagating neuronal stem cell line has been developed as well as a culture medium for growing and maintaining the cells. The cells can be harvested from pre-retinal membranes of eyes with congenital ocular defects during conventional vitreoretinal surgery, a procedure that does not harm the retina. Under specific conditions, the cells differentiate into mature cells and express markers consistent with mature neurons and retinal elements including the presence of neurofilaments, several surface receptors and sodium and potassium channels, all characteristic of functioning neuronal cells. The adult stem-cells differentiate in the eyes and can be used in allogeneic transplantation in cell-based therapy of retinal disorders (no evidence of graft vs. host disease). The cells are currently being transplanted into retina of mice with retinal degeneration. The new adult retinal stem cell line: does not require the destruction of the retina for its collection, differentiates into nature neuronal cells in vitro and in the eye and eludes the ethical controversy and government restrictions on embryonic stem cells.

Innovation Details

File Number: SERI-219 

Other Information:

M.D. Kameran Lashkari

Mary Chatterton, Director of Corporate Alliances.

IP Protection

License Online

This innovation currently is not available for online licensing. Please contact the case manager at Schepens Eye Research Institute for more information.

Request more info via email request more info

No people are currently associated with this innovation.

Download Technology Brief (PDF)

Followed By

Follow this innovation

No one is following this innovation.

Related Tags

Find more innovations

February 11, 2009

13,188 members 17,559 innovations 176 organizations


Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...